An at-risk group indicates the possibility that the condition may be associated with the risk of vital nutrient deficiency. The complaint insomnia indicates a vital nutrient deficiency for:
- Magnesium
Within the framework of micronutrient medicine (vital substances), vital substances (micronutrients) are used for supportive therapy of sleep disorders:
- Vitamin B12
- Magnesium
- Amino acid tryptophan
The above vital substance recommendations were created with the help of medical experts. All statements are supported by scientific studies with high levels of evidence. For a therapy recommendation, only clinical studies with the highest levels of evidence (grade 1a/1b and 2a/2b) were used, which due to their high significance prove the therapy recommendation. These data are updated at certain intervals.
